Portsmouth City Council Staff Flu Vaccination Programme

A Contract Award Notice
by PORTSMOUTH CITY COUNCIL

Source
Find a Tender
Type
Contract (Services)
Duration
not specified
Value
£12K
Sector
HEALTH
Published
01 Oct 2025
Delivery
not specified
Deadline
n/a

Concepts

Location

Portsmouth

Geochart for 2 buyers and 1 suppliers

2 buyers

1 supplier

Description

Portsmouth City Council intends to award a contract to an existing provider for the provision of an existing service, the staff flu vaccination programme. The aim of the service is to increase the provision of and access to seasonal influenza immunisation for eligible employees of Portsmouth City Council, especially among those working with vulnerable/at risk clients. It is intended that the initial contract term will be from 15th October 2025 to 31st March 2027, with the option to extend for a further 3 years, with a total contract value of £12,500. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023, following Direct Award Process C. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice.

Total Quantity or Scope

Portsmouth City Council intends to award a contract to an existing provider for the provision of an existing service, the staff flu vaccination programme, following Direct Award Process C under the Provider Selection Regime (PSR) Regulations 2023. This Service will increase the provision of and access to seasonal influenza immunisation for eligible employees of Portsmouth City Council (including Councillors and Port staff), HIOW ICB and Gosport Borough Council. In particular, the quadrivalent seasonal influenza vaccine that the Joint Committee on Vaccinations and Immunisations (JCVI) recommend is issued to frontline health and social care workers. The provision of this service is expected to facilitate flu vaccine uptake, especially among those working with vulnerable/at risk clients. This is to reduce the serious morbidity and mortality of influenza by immunising those who care for individuals who are more likely to have a serious or complicated illness should they develop influenza. It is intended that the initial contract term will be from 15th October 2025 to 31st March 2027, with the option to extend for a further 3 years, with a total contract value of £12,500.

Award Detail

1 JCL (Portsmouth)
  • Num offers: 1
  • Value: £12,500
  • Contractor is an SME.

Renewal Options

It is intended that the initial contract term will be from 15th October 2025 to 31st March 2027, with the option to extend for a further 3 years, with a total contract value of £12,500.

Award Criteria

PRICE _

CPV Codes

  • 85149000 - Pharmacy services

Indicators

  • Options are available.
  • Award on basis of price.

Other Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or the Procurement Act 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by midnight on 13th October 2025 via email to phcontracts@portsmouthcc.gov.uk. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. The decisions makers are commissioners of the Public Health directorate at Portsmouth City Council. There were no conflicts of interest identified. Through the assessment of the existing provider in accordance with each of the Key Criteria listed under the PSR Regulations 2023, Direct Award Process C, it was identified that the existing provider satisfies the original contract with no concerns identified. They will likely be able to satisfy the new contract to a sufficient standard. The key criteria were taken in consideration as follows: Quality and innovation (20%), Value (20%), Integration, Collaboration and Service Sustainability (15%), Improving access, reducing health inequalities and facilitating choice (30%), Social Value (15%)

Reference

Domains